The Pacific Cancer Research Consortium (PCRC), an NCORP Community Site
The Pacific Cancer Research Consortium (PCRC), an NCORP Community Site
批准号:
9122345
负责人:
Benjamin Bridges
金额:
$132.56万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-08-01 至 2019-07-31
关键词:
AlaskaBasic ScienceCaliforniaCancer CenterCancer Trials Support UnitCaringCatchment AreaClinical InvestigatorClinical ResearchClinical TrialsCollaborationsCollectionCommunitiesCommunity Clinical Oncology ProgramConduct Clinical TrialsData CollectionData QualityData Storage and RetrievalDatabasesDevelopmentFosteringFundingGenomic medicineGrantHealthIdahoIncentivesIndustryInstitutesInstitutionInstitutional Review BoardsJointsLeadershipMalignant NeoplasmsMedical centerMentorsMethodsMinority ParticipationOregonPacific NorthwestPatient RecruitmentsPatientsPopulationProviderResearchResearch DesignResearch InfrastructureResearch MethodologyResearch PersonnelRetrospective StudiesRoleRuralSamplingScienceSiteSpecimenStructureSurveysTumor BankUnderserved PopulationUnited StatesWashingtonWorkanticancer researchbasecancer carecancer clinical trialcancer health disparitycancer therapycare deliveryclinical practicedata managementdesignexperienceknowledge translationmeetingsmembernovel strategiesoncologyprogramsresearch studysoundtargeted treatmenttreatment centertumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The Pacific Cancer Research Consortium (PCRC) brings together community cancer treatment centers in the Western United States to form an NCI Community Oncology Research Program (NCORP) Community Site. The PCRC includes Swedish Cancer Institute in Seattle and its former U10 affiliates (the Puget Sound Oncology Consortium), Providence Portland Medical Center in Portland and its former Community Clinical Oncology Program affiliates (the Western Oncology Research Consortium), and Mountain States Tumor Institute in Boise. Under a multiple PI/PD structure, the 3 primary components of the PCRC will define and facilitate the clinical trial and cancer care delivery research agenda across 24 participating components and 14 sub-components in Washington, Oregon, Idaho, Alaska, and California. Each of our primary component sites has decades of experience conducting clinical trials in cancer and plan to participate in all aspect of study design and conduct NCI-approved clinical studies and cancer care delivery research, with particular focus on facilitating the participation of minorities and underserved populations across all study types and settings within our catchment areas, providing bio specimen banking and sharing practices within the participating institutions and with our research bases, and incorporating genomic medicine and targeted therapies into our portfolio of research capabilities. We also plan to build
a multicenter infrastructure and research agenda for cancer care delivery research to support the trials proposed by the NCTN, allowing us to participate in the development of novel approaches to CC DR studies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金